Loading clinical trials...
Loading clinical trials...
The objective of this observational study HOPSCOTcH-WILL II is to provide an accurate and detailed account of current Von Willebrand Disease (VWD) therapeutic management by collecting real-life data o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nantes University Hospital
NCT06820515 · Hemophilia, Thrombosis, and more
NCT05773638 · Von Willebrand Diseases
NCT06205095 · Von Willebrand Diseases
NCT04119908 · Von Willebrand Diseases, Glanzmann Thrombasthenia
NCT04810702 · Von Willebrand Diseases
CHU Angers
Angers
CHR de Brest
Brest
CH Le Mans
Le Mans
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions